Yale receives $10 million to study tobacco use: Research grant comes from three national organizations

New Haven, Conn. -- Yale Medical School researchers will examine why some smokers are resistant to current smoking cessation treatments with a $10 million grant from The National Institute on Drug Abuse (NIDA), the National Cancer Institute (NCI) and The Robert Wood Johnson Foundation.

The five-year grant is part of an $84 million initiative by these three organizations to create national Transdisciplinary Tobacco Use Research Centers (TTURC) for studying tobacco use, new ways to reduce its use and combat its consequences. Led by Principal Investigator Stephanie S. O'Malley, Ph.D., Yale's new TTURC center consists of a multidisciplinary group of scientists conducting five major tobacco research projects.

"The goal of our center is to improve tobacco addiction treatment by studying why current treatments fail and developing new behavioral and drug treatments that address these factors," said O'Malley, professor of psychiatry and director of the Division of Substance Abuse Research at Yale Medical School. "It is critically important that more effective smoking cessation treatments be developed, because most smokers try to quit only once every three to four years."

Despite trends that show declining smoking rates in the general population, rates are declining less in female smokers, smokers with depression and smokers who are heavy drinkers. The five Yale studies will focus on these often-overlooked segments of the smoking population.

"Given societal pressures against smoking, the majority of current smokers are either in the process of quitting or interested in stopping, but many find it difficult to quit and are treatment resistant," said Marina Picciotto, assistant professor of psychiatry and pharmacology at Yale. "In order to treat this group of smokers, we have to increase understanding of alcohol use and depression, which are known factors in treatment failure."

The center grant provides a rare opportunity to examine these risk

Contact: Karen N. Peart
Yale University

Page: 1 2 3

Related medicine news :

1. UIC professor receives international humanitarian award
2. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
3. Epidemiologist Trichopoulos receives $5.8 million Department of Defense Innovator Award
4. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
5. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
6. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
7. American Academy of Neurology program receives Grassroots Award
8. Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers
9. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI
10. Pfizers antifungal medicine VFEND receives FDA approval
11. Shire receives US FDA approval of EQUETRO (TM) for bipolar disorder

Post Your Comments:

(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
Breaking Medicine Technology:
Cached News: